Oxalate nephropathy complicating Roux-en-Y Gastric bypass: An underrecognized cause of irreversible renal failure

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 6, 2008, Pages 1676-1683

  Nasr, Samih H ^a   D'Agati, Vivette D ^a   Said, Samar M ^a   Stokes, Michael B ^a   Largoza, Maria V ^b   Radhakrishnan, Jai ^c   Markowitz, Glen S ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b Medical Associates of Drexel Hill Inc   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE; CREATININE;

AGED; ARTICLE; CHRONIC KIDNEY FAILURE; DISEASE COURSE; FEMALE; GLOMERULUS; HUMAN; KIDNEY DISEASE; KIDNEY TUBULE; MALE; METABOLISM; MIDDLE AGED; MORBID OBESITY; PATHOLOGY; RENAL REPLACEMENT THERAPY; RISK FACTOR; STOMACH BYPASS; STOMACH TUMOR;

AGED; CALCIUM OXALATE; CREATININE; DISEASE PROGRESSION; FEMALE; GASTRIC BYPASS; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; MIDDLE AGED; OBESITY, MORBID; RENAL DIALYSIS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 58149354522     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02940608     Document Type: Article

References (27)

1. Dobbins JW, Binder HJ: Importance of the colon in enteric hyperoxaluria. N Engl J Med 10; 296: 298-301, 1977
2. Andersson H, Filipsson S, Hultén L: Urinary oxalate excretion related to ileocolic surgery in patients with Crohn's disease. Scand J Gastroenterol 13: 465469, 1978
3. Dobbins JW, Binder HJ: Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology 70: 1096-1100, 1976
4. Mole DR, Tomson CR, Mortensen N, Winearls CG: Renal complications of jejuno-ileal bypass for obesity. QJM 94: 69-77, 2001
5. Ehlers SM, Posalaky Z, Strate RG, Quattlebaum FW: Acute reversible renal failure following jejunoileal bypass for morbid obesity: A clinical and pathological (EM) study of a case. Surgery 82: 629-634, 1977
6. Requarth JA, Burchard. KW, Colacchio TA, Stukel TA, Mott LA, Greenberg ER, Weismann RE: Long-term morbidity following jejunoileal bypass: The continuing potential need for surgical reversal. Arch Surg 130: 318-325, 1995
7. Hofmann AF, Laker MF, Dharmsathaphorn K, Sherr HP, Lorenzo D: Complex pathogenesis of hyperoxaluria after jejunoileal bypass surgery: Oxalogenic substances in diet contribute to urinary oxalate. Gastroenterology 84: 293-300, 1983
8. Nguyen NT, Silver M, Robinson M, Needleman B, Hartley G, Cooney R, Catalano R, Dostal J, Sama D, Blankenship J, Burg K, Stemmer E, Wilson SE: Result of a national audit of bariatric surgery performed at academic centers: A 2004 University HealthSystem Consortium Benchmarking Project. Arch Surg 141: 445-450, 2006
9. MacLean LD, Rhode BM, Nohr CW: Late outcome of isolated gastric bypass. Ann Surg 231: 524-528, 2000
10. Asplin JR, Coe FL: Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol 177: 565-569, 2007
11. Sinha MK, Collazo-Clavell ML, Rule A, Milliner DS, Nelson W, Sarr MG, Kumar R, Lieske JC: Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int 72: 100-107, 2007
12. Nelson WK, Houghton SG, Milliner DS, Lieske JC, Sarr MG: Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: Potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis. 1: 481-485, 2005
13. Lieske JC, Kumar R, Collazo-Clavell ML: Nephrolithiasis after bariatric surgery for obesity. Semin Nephrol 28: 163-173, 2008
14. State-specific prevalence of obesity among adults - United States, 2005. MMWR Morb Mortal Wkly Rep 55: 985-988, 2006
15. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295: 1549-1555, 2006
16. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A,, Leitzmann MF: Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355: 763-778, 2006
17. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB: Years of life lost due to obesity. JAMA 289: 187-193, 2003
18. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD: Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 59: 1498-1509, 2001
19. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dah1gren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers. T, Stenlöf K, Torgerson J, Agren G, Carlsson LM, Swedish Obese Subjects Study: Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357: 741-752, 2007
20. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K: Bariatric surgery: A systematic review and meta-analysis. JAMA 292: 1724-1737, 2004
21. Shinogle JA, Owings MF, Kozak LJ: Gastric bypass as treatment for obesity: Trends, characteristics, and complications. Obes Res 13: 2202-2209, 2005
22. Tessier DJ, Eagon JC: Surgical management of morbid obesity. Curr Probl Surg 45: 68-137, 2008
23. Yao JC, Crane CH, Mansfield PF. Carcinoma of the stomach. In: Cancer Medicine, 7th Ed., edited by Kufe DW, Frei E, Holland JF, Weichselbaum RR, Pollock RE, Bast RC, Hong WK, Hait WN, Hamilton, Ontario, Canada, BC Decker, 2006, pp 1268-1292
24. Armbrecht U, Lundell L, Lindstedt G, Stockbruegger RW: Causes of malabsorption after total gastrectomy with Roux-en-Y reconstruction. Acta Chir Scand 154: 37-41, 1988
25. Bradley EL 3rd, Isaacs JT, Mazo JD, Hersh T, Chey WY: Pathophysiology and significance of malabsorption after Roux-en-Y reconstruction. Surgery 81: 684-691, 1977
26. Lieske JC, Regnier C, Dillon JJ: Use of sevelamer hydrochloride as an oxalate binder. J Urol 179: 1407-1410, 2008
27. Verani R, Nasir M, Foley R: Granulomatous interstitial nephritis after a jejunoileal bypass: An ultrastructural and histochemical study. Am J Nephrol 9: 51-55, 1989